Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib and Itacitinib in Relapsed or Refractory Hodgkin Lymphoma
NCT02456675Phase 2Terminated
- Sponsor
- Incyte
- Start
- Jun 2015
- Primary completion
- Dec 2016
01
Overview
Phase 2, open-label trial of parsaclisib in Hodgkin lymphoma (HL), sponsored by Incyte. Started Jun 2015; status: terminated.
02
Drugs
parsaclisib
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT02456675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456675.